Improved HIV and Substance Abuse Treatment Outcomes for Released HIV-Infected Prisoners: The Impact of Buprenorphine Treatment
Springer SA, Chen S, Altice FL. Improved HIV and Substance Abuse Treatment Outcomes for Released HIV-Infected Prisoners: The Impact of Buprenorphine Treatment. Journal Of Urban Health 2010, 87: 592-602. PMID: 20177974, PMCID: PMC2900572, DOI: 10.1007/s11524-010-9438-4.Peer-Reviewed Original ResearchConceptsOpioid agonist therapySubstance abuse treatment outcomesTreatment outcomesNon-detectable viral loadOpioid treatment outcomesBuprenorphine/naloxoneDSM-IV criteriaAgonist therapyAntiretroviral therapyCD4 countOpioid cravingAdverse eventsBuprenorphine treatmentOpioid dependenceViral loadUrine testingHIVTherapyVulnerable populationsWeeksOutcomesNLXTrialsInductionLikert scaleCommentary on Larney (2010): A call to action—opioid substitution therapy as a conduit to routine care and primary prevention of HIV transmission among opioid‐dependent prisoners
Springer SA. Commentary on Larney (2010): A call to action—opioid substitution therapy as a conduit to routine care and primary prevention of HIV transmission among opioid‐dependent prisoners. Addiction 2010, 105: 224-225. PMID: 20078481, PMCID: PMC2825564, DOI: 10.1111/j.1360-0443.2009.02893.x.Peer-Reviewed Original Research